Japan’s Chugai Forecasts Record-Setting Profit Decline In 2008
This article was originally published in PharmAsia News
Executive Summary
Chugai Pharmaceutical of Japan, a Roche Holding subsidiary, expects its profits this year to decline more than in any year in its 24-year history, the company reported. The company cited lower drug prices ordered by the government and drops in sales of its three best-selling drugs. Chugai also voluntarily lowered the price of its best-selling Epogin last July in an effort to compete with Kirin Holdings' competing product. (Click here for more